glistroma TEMOZOLOMIDE

Introduction to glistroma

Glistroma is a medication available in tablet form, primarily used to treat certain aggressive brain tumors, such as glioblastoma multiforme and anaplastic astrocytoma. Glistroma works by targeting cancer cells in the brain.

Composition of glistroma

Glistroma contains the active ingredient Temozolomide, which is an alkylating agent. This compound interferes with the DNA of cancer cells, preventing them from growing and dividing, thereby stopping cancer cell multiplication.

Uses of glistroma

• Treatment of glioblastoma multiforme
• Treatment of anaplastic astrocytoma

Side effects of glistroma

• Common side effects: nausea, vomiting, fatigue
• Serious side effects: severe bone marrow suppression, increased infection risk

Precautions of glistroma

Glistroma can lower blood cell counts, increasing the risk of infections. It is not recommended for use during pregnancy due to potential harm to the unborn baby. Patients with severe bone marrow suppression should avoid using this medication.

How to Take glistroma

Glistroma is taken orally, usually as a tablet. The typical starting dose for adults is 150 mg/m² once daily for five days in a 28-day cycle. It should be taken on an empty stomach, either one hour before or two hours after a meal. Always follow your doctor's instructions for the correct dosage and administration.

Conclusion of glistroma

Glistroma, containing the active ingredient Temozolomide, is a part of the alkylating agents therapeutic class. It is primarily used to treat aggressive brain tumors like glioblastoma multiforme and anaplastic astrocytoma. Manufactured with precision, glistroma offers a targeted approach to cancer treatment. Always consult your healthcare provider for personalized advice and guidance on using glistroma effectively.